Glass flakes prompt two American Regent recalls

Glass delamination is being cited as the reason for two more drug recalls. American Regent is taking back one lot of cyanide-poisoning treatment sodium thiosulfate and one lot of intravenous-fluid supplement potassium phosphates injection. Both are packaged in vials and made by the drug distributor's parent, Luitpold Pharmaceuticals, owned by Daiichi Sankyo.

The sodium thiosulfate recall is for 10-mL vials while the potassium phosphates recall involves 5-mL units. Both recalls, announced late last week, reach the user level.

Delamination yields glass particle contamination. It has been the cause now of seven parenteral recalls, according to industry group Rx-360. Among them is another American Regent recall from late December of single-dose vials of sodium bicarbonate. Causes may include chemicals used in glass processing and drug formulation characteristics.

- see the American Regent announcement

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)